Telmisartan and Amlodipine Single‐Pill Combinations vs Amlodipine Monotherapy for Superior Blood Pressure Lowering and Improved Tolerability in Patients With Uncontrolled Hypertension: Results of the TEAMSTA‐5 Study

No abstract is available for this paper.

• Publication year

  2011

• Venue

  The Journal of Clinical Hypertension

• Publication date

  2011-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1751-7176.2011.00468.xPMID 21762357PMCID PMC8108958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

  2010cited by this paper
• Olmesartan Medoxomil plus Amlodipine Increases Efficacy in Patients with Moderate-to-Severe Hypertension after Monotherapy

  2009cited by this paper
• Original Research: Telmisartan plus Amlodipine in Patients with Moderate or Severe Hypertension: Results from a Subgroup Analysis of a Randomized, Placebo-Controlled, Parallel-Group, 4 × 4 Factorial Study

  2009cited by this paper
• Telmisartan: A Different Angiotensin II Receptor Blocker Protecting a Different Population?

  2009cited by this paper
• Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy

  2009cited by this paper
• Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy

  2009cited by this paper
• Efficacy and Safety of Long‐Term Treatment With the Combination of Amlodipine Besylate and Olmesartan Medoxomil in Patients With Hypertension

  2009cited by this paper
• Results of Treatment With Telmisartan‐Amlodipine in Hypertensive Patients

  2009cited by this paper
• Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.

  2009cited by this paper
• The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.

  2008cited by this paper
• Results of Increasing Doses of Hydrochlorothiazide in Combination With an Angiotensin Receptor Blocker in Patients With Uncontrolled Hypertension

  2008cited by this paper
• Efficacy of the Combination of Amlodipine and Valsartan in Patients With Hypertension Uncontrolled With Previous Monotherapy: The Exforge in Failure After Single Therapy (EX‐FAST) Study

  2008cited by this paper
• 2013 ESH/ESC Guidelines for the management of arterial hypertension

  2007cited by this paper
• Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients

  2007cited by this paper
• Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin–angiotensin system blockade

  2007cited by this paper
• Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way crossover study.

  2007cited by this paper
• Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.

  2007cited by this paper
• Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension.

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• [The "LOTHAR" study: evaluation of efficacy and tolerability of the fixed combination of amlodipine and losartan in the treatment of essential hypertension].

  2006cited by this paper
• Effects of Monotherapy and Combination Therapy on Blood Pressure Control and Target Organ Damage: A Randomized Prospective Intervention Study in a Large Population of Hypertensive Patients

  2006cited by this paper
• Prevention of Cardiovascular Events With an Antihypertensive Regimen of Amlodipine Adding Perindopril as Required Versus Atenolol Adding Bendroflumethiazide as Required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A Multicentre Randomised Controlled Tri

  2006cited by this paper
• Estudo "LOTHAR": avaliação de eficácia e tolerabilidade da combinação fixa de anlodipino e losartana no tratamento da hipertensão arterial primária

  2006cited by this paper
• Telmisartan

  2006cited by this paper
• High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension

  2005cited by this paper
• Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers.

  2005cited by this paper
• Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri

  2005cited by this paper
• Sustained antihypertensive activity of telmisartan compared with valsartan

  2004cited by this paper
• Evaluation of Angiotensin II Receptor Blockers for 24‐Hour Blood Pressure Control: Meta‐Analysis of a Clinical Database

  2003cited by this paper
• The Effects of Amlodipine Compared to Losartan in Patients With Mild to Moderately Severe Hypertension

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002)

  2003cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well‐being

  1997cited by this paper

• Evaluation of Effectiveness and Safety of Telmisartan and Amlodipine Fixed-Dose Combination in Indian Patients with Hypertension: TACT-India Study.

  2026cites this paper
• Decision-Making for Lymphedema Diagnostic and Surveillance Measures: A Case-Based Approach

  2025cites this paper
• Dyskalemia Prior to and After Initiation of a Fixed Dose Combination of Telmisartan and Amlodipine in Adults with Hypertension in Bangladesh

  2025cites this paper
• Effectiveness and Safety of the Telmisartan and Amlodipine Fixed-dose Combination in Managing Hypertension among Indian Patients (TACT India Study): Rationale and Study Design.

  2024cites this paper
• Efficacy of single‐pill combination in uncontrolled essential hypertension: A systematic review and network meta‐analysis

  2023cites this paper
• Contribution of single-pill combinations in the management of hypertension: perspectives from China, Europe and the USA

  2023cites this paper
• Telmisartan Plus Amlodipine as the Preferred Initial Combination in Newly Diagnosed Indian Patients with Hypertension: An Expert Consensus Statements.

  2023cites this paper
• An anchored simulated treatment comparison of uptitration of amlodipine compared with a low-dose combination treatment with amlodipine 5 mg/bisoprolol 5 mg for patients with hypertension suboptimally controlled by amlodipine 5 mg monotherapy

  2022cites this paper
• A growing evidence base for the fixed-dose combination of bisoprolol and amlodipine to manage hypertension

  2022cites this paper
• Effect of a fixed-dose combination of Telmisartan/S-amlodipine on circadian blood pressure compared with Telmisartan monotherapy: TENUVA-BP study

  2022cites this paper
• Effective strategies for prevention of cardiovascular complications in elderly patients with arterial hypertension and obesity (clinical example)

  2020cites this paper
• [Current position of a fixed combination telmisartan with amlodipine in treatment of essential arterial hypertension].

  2019cites this paper
• RATIONALITY OF THE FIXED DOSE COMBINATION OF TELMISARTAN AND AMLODIPINE IN MANAGEMENT OF MILD TO MODERATE HYPERTENSION UNRESPONSIVE TO LOW DOSE MONOTHERAPY

  2017cites this paper
• High-dose calcium channel blocker (CCB) monotherapy vs combination therapy of standard-dose CCBs and angiotensin receptor blockers for hypertension: a meta-analysis

  2017cites this paper
• Comparison of the Efficacy and Safety of Fixed-dose S-Amlodipine/Telmisartan and Telmisartan in Hypertensive Patients Inadequately Controlled with Telmisartan: A Randomized, Double-blind, Multicenter Study.

  2016cites this paper
• Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes

  2016cites this paper
• Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study

  2016influential citation
• Critical Analysis of Cardiovascular and Central Nervous System Fixed Dose Combinations Available in Indian Market.

  2016cites this paper
• Meta-analysis of the efficacy and safety of adding an angiotensin receptor blocker (ARB) to a calcium channel blocker (CCB) following ineffective CCB monotherapy.

  2015influential citation
• A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension.

  2015cites this paper
• Jan Václavík

  2015influential citation
• Reasons for Switching Antihypertensive Medication in General Practice

  2014cites this paper
• Efficacy and Tolerability of Telmisartan Plus Amlodipine in Asian Patients Not Adequately Controlled on Either Monotherapy or on Low-Dose Combination Therapy

  2014cites this paper
• Azilsartan, Aliskiren, and Combination Antihypertensives Utilizing Renin–Angiotensin–Aldosterone System Antagonists

  2014cites this paper
• Comparative study of high dose mono-therapy of amlodipine or telmisartan, and their low dose combination in mild to moderate hypertension.

  2014cites this paper
• A randomized, double-blind study to evaluate the efficacy and safety of a single-pill combination of telmisartan 80 mg/amlodipine 5 mg versus amlodipine 5 mg in hypertensive Asian patients

  2014cites this paper
• Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy

  2013cites this paper
• Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats

  2013cites this paper
• Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension

  2013cites this paper
• Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study

  2013cites this paper
• Combination therapy for hypertension 2013: an update.

  2013cites this paper
• Treatment algorithms for hypertension: a practical approach

  2013cites this paper
• Early combination therapy with telmisartan plus amlodipine for rapid achievement of blood pressure goals

  2013cites this paper
• COMBINATION THERAPY OF ARTERIAL HYPERTENSION - OUR EXPECTATIONS

  2013cites this paper
• Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients)

  2013cites this paper
• Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.

  2012cites this paper
• Long-Term Tolerability and Efficacy of Single-Pill Combinations of Telmisartan 40-80 mg Plus Amlodipine 5 or 10 mg in Patients Whose Blood Pressure Was Not Initially Controlled by Amlodipine 5-10 mg: Open-Label, Long-Term Follow-Ups of the TEAMSTA-5 and TEAMSTA-10 Studies.

  2012cites this paper
• Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations

  2012cites this paper
• Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009

  2012cites this paper
• Astra Tech publications

  2012cites this paper
• Single-pill combination — role in antihypertensive therapy

  2011cites this paper
• New telmisartan/amlodipine single-pill combination offers both efficacy and tolerability.

  2011cites this paper
• O R I G I N a L I N V E S T I G a T I O N Open Access

  year unknowncites this paper
• Vascular Health and Risk Management Dovepress a Review of the Benefits of Early Treatment Initiation with Single-pill Combinations of Telmisartan with Amlodipine or Hydrochlorothiazide

  year unknowncites this paper